The Journal of
Clinical Psychiatry

Volume 60 • 1999 • Supplement 1

Article

Article

Introduction. Pharmacoeconomics of Treatment-Resistant Schizophrenia

J Clin Psychiatry 1999;60(suppl 1):3-3

M. Annette Hanson, MD^{Symposium Chair}

Article

The Economic Impact of Schizophrenia

J Clin Psychiatry 1999;60(suppl 1):4-6

Dorothy P. Rice

Article

Pharmacoeconomic Evaluation of Treatments for Refractory Schizophrenia: Clozapine-Related Studies

J Clin Psychiatry 1999;60(suppl 1):7-11

Dennis A. Revicki, PhD

Article

New Antipsychotic Agents: Emerging Clinical Profiles

J Clin Psychiatry 1999;60(suppl 1):12-17

Peter F. Buckley, MD

Article

Clozapine for Refractory Schizophrenia: The Illinois Experience

J Clin Psychiatry 1999;60(suppl 1):18-22

Robert W. Buckman, PhD; Randy D. Malan, RPh

Article

New vs. Old Antipsychotics: The Texas Experience

J Clin Psychiatry 1999;60(suppl 1):23-25

William H. Reid, MD, MPH

Article

Pharmacoeconomics of Schizophrenia in the 21st Century

J Clin Psychiatry 1999;60(suppl 1):26-27

M. Annette Hanson, MD

Article

Consensus Discussion: Pharmacoeconomics of Treatment-Resistant Schizophrenia

J Clin Psychiatry 1999;60(suppl 1):28-30